Corcept Therapeutics Incorporated
DE ˙ DB ˙ US2183521028
63,24 € ↓ -0,74 (-1,16%)
2026-06-05
DEL PRIS
SecurityDE:HTD / Corcept Therapeutics Incorporated
InstitutionGotham Asset Management, LLC
ManagerJoel Greenblatt
Latest Disclosed Ownership17,918 shares
Latest Disclosed Value $ 722,275
Gotham Asset Management, LLC reports 3.26% increase in ownership of HTD / Corcept Therapeutics Incorporated

On May 15, 2026 - Gotham Asset Management, LLC filed a 13F-HR form disclosing ownership of 17,918 shares of Corcept Therapeutics Incorporated (DE:HTD) valued at $617,992 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 17,352 shares of Corcept Therapeutics Incorporated. This represents a change in shares of 3.26% during the quarter. The current value of the position is $1,133,134 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CORCEPT THERAPEUTICS COM 218352102 17,918 566 3.26 722 19.73 0.0022
2026-02-17 2025-12-31 13F CORCEPT THERAPEUTICS COM 218352102 17,352 -10 -0.06 604 -58.18 0.0022
2025-11-14 2025-09-30 13F CORCEPT THERAPEUTICS COM 218352102 17,362 50 0.29 1,443 13.54 0.0063
2025-08-14 2025-06-30 13F CORCEPT THERAPEUTICS COM 218352102 17,312 -111 -0.64 1,271 -36.18 0.0076
2025-05-15 2025-03-31 13F CORCEPT THERAPEUTICS COM 218352102 17,423 -1,714 -8.96 1,990 106.43 0.0166
2025-02-14 2024-12-31 13F CORCEPT THERAPEUTICS COM 218352102 19,137 523 2.81 964 11.96 0.0091
2024-11-14 2024-09-30 13F CORCEPT THERAPEUTICS COM 218352102 18,614 -6,341 -25.41 861 6.30 0.0089
2024-08-14 2024-06-30 13F CORCEPT THERAPEUTICS COM 218352102 24,955 -13,717 -35.47 811 -16.84 0.0105
2024-05-15 2024-03-31 13F CORCEPT THERAPEUTICS COM 218352102 38,672 21,009 118.94 974 69.98 0.0147
2024-02-14 2023-12-31 13F CORCEPT THERAPEUTICS COM 218352102 17,663 -73 -0.41 574 18.63 0.0106
2023-11-14 2023-09-30 13F CORCEPT THERAPEUTICS COM 218352102 17,736 -4,066 -18.65 483 -0.41 0.0100
2023-08-14 2023-06-30 13F CORCEPT THERAPEUTICS COM 218352102 21,802 -7,405 -25.35 485 -23.26 0.0106
2023-05-15 2023-03-31 13F CORCEPT THERAPEUTICS COM 218352102 29,207 -14,458 -33.11 633 -28.67 0.0153
2023-02-14 2022-12-31 13F CORCEPT THERAPEUTICS COM 218352102 43,665 5,510 14.44 887 -9.41 0.0250
2022-11-14 2022-09-30 13F CORCEPT THERAPEUTICS COM 218352102 38,155 -9,166 -19.37 978 -13.07 0.0293
2022-08-15 2022-06-30 13F CORCEPT THERAPEUTICS COM 218352102 47,321 -2,119 -4.29 1,125 1.08 0.0361
2022-05-16 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 49,440 594 1.22 1,113 15.10 0.0345
2022-02-14 2021-12-31 13F CORCEPT THERAPEUTICS COM 218352102 48,846 30,279 163.08 967 164.93 0.0312
2021-11-15 2021-09-30 13F CORCEPT THERAPEUTICS COM 218352102 18,567 3,188 20.73 365 7.99 0.0148
2021-08-16 2021-06-30 13F CORCEPT THERAPEUTICS COM 218352102 15,379 -1,373 -8.20 338 -15.29 0.0143
2021-05-17 2021-03-31 13F CORCEPT THERAPEUTICS COM 218352102 16,752 -9,811 -36.93 399 -42.59 0.0178
2021-02-16 2020-12-31 13F CORCEPT THERAPEUTICS COM 218352102 26,563 -16,822 -38.77 695 -7.95 0.0230
2020-11-16 2020-09-30 13F CORCEPT THERAPEUTICS COM 218352102 43,385 14,374 49.55 755 54.71 0.0242
2020-08-13 2020-06-30 13F CORCEPT THERAPEUTICS COM 218352102 29,011 -43,332 -59.90 488 -43.26 0.0146
2020-05-15 2020-03-31 13F CORCEPT THERAPEUTICS COM 218352102 72,343 -5,791 -7.41 860 -8.99 0.0239
2020-02-14 2019-12-31 13F CORCEPT THERAPEUTICS COM 218352102 78,134 29,674 61.23 945 37.96 0.0174
2019-11-14 2019-09-30 13F CORCEPT THERAPEUTICS COM 218352102 48,460 -27,727 -36.39 685 -19.32 0.0121
2019-08-14 2019-06-30 13F CORCEPT THERAPEUTICS COM 218352102 76,187 -39,642 -34.22 849 -37.57 0.0135
2019-05-15 2019-03-31 13F CORCEPT THERAPEUTICS COM 218352102 115,829 -6,964 -5.67 1,360 -17.12 0.0199
2019-02-14 2018-12-31 13F CORCEPT THERAPEUTICS COM 218352102 122,793 66,533 118.26 1,641 107.98 0.0255
2018-11-14 2018-09-30 13F CORCEPT THERAPEUTICS COM 218352102 56,260 -13,761 -19.65 789 -28.34 0.0109
2018-08-14 2018-06-30 13F CORCEPT THERAPEUTICS COM 218352102 70,021 49,309 238.07 1,101 222.87 0.0159
2018-05-15 2018-03-31 13F CORCEPT THERAPEUTICS COM 218352102 20,712 2,878 16.14 341 5.90 0.0048
2018-02-14 2017-12-31 13F CORCEPT THERAPEUTICS COM 218352102 17,834 -48,616 -73.16 322 -74.88 0.0047
2017-11-14 2017-09-30 13F CORCEPT THERAPEUTICS COM 218352102 66,450 6,793 11.39 1,282 82.10 0.0188
2017-08-14 2017-06-30 13F CORCEPT THERAPEUTICS COM 218352102 59,657 47,968 410.37 704 450.00 0.0099
2017-05-15 2017-03-31 13F CORCEPT THERAPEUTICS COM 218352102 11,689 -26,321 -69.25 128 -53.62 0.0016
2017-02-14 2016-12-31 13F CORCEPT THERAPEUTICS COM 218352102 38,010 17,102 81.80 276 102.94 0.0036
2016-11-14 2016-09-30 13F CORCEPT THERAPEUTICS COM 218352102 20,908 5,884 39.16 136 65.85 0.0018
2016-08-15 2016-06-30 13F CORCEPT THERAPEUTICS COM 218352102 15,024 15,024 0.00 82 0.0010
2016-05-16 2016-03-31 13F CORCEPT THERAPEUTICS COM 218352102 0 -17,347 -100.00 0 -100.00
2016-02-16 2015-12-31 13F CORCEPT THERAPEUTICS COM 218352102 17,347 126 0.73 86 32.31 0.0009
2015-11-16 2015-09-30 13F CORCEPT THERAPEUTICS COM 218352102 17,221 17,221 65 0.0006
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.